Reddit
Linking pages
Related searches:

Search whole site: site:doi.org

Search title: Novo Nordisk study finds that semaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabetes

See how to search.